missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Human IL-36 gamma/IL-1F9 (aa 18-169) Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
N.V.
Spezifikation
| Gen-ID (Entrez) | 56300 |
|---|---|
| Molekulargewicht | 17 kDa |
| Name | IL-36 gamma/IL-1F9 (aa 18-169) |
| Menge | 10μg |
| Quelle | E. coli-derived human IL-36 gamma/IL-1F9 protein Ser18-Asp169 |
Beschreibung
The Recombinant Human IL-36 gamma/IL-1F9 (aa 18-169) Protein is derived from E. coli. The Recombinant Human IL-36 gamma/IL-1F9 (aa 18-169) Protein has been validated for the following applications: Bioactivity.Spezifikation
| 56300 | |
| IL-36 gamma/IL-1F9 (aa 18-169) | |
| E. coli-derived human IL-36 gamma/IL-1F9 protein Ser18-Asp169 | |
| Unconjugated | |
| 95%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
| 17 kDa | |
| 10μg | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. | |
| Recombinant |